Overview
Omixys supplies and supports life-science technologies in Central and Eastern Europe, including tools for research on transcriptomes, proteins, cells, and organisms. Its offering includes flow cytometry, imaging, PCR systems, and laboratory automation.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 45 days early.
- 202509/06/2026
- 202413/06/2025
- 202311/06/2024
- 202220/06/2023
- 202129/06/2022
- 202010/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Flow cytometry
- Cell imaging systems
- Laboratory automation
- Protein analyzers
- Cell culture chambers
Website technology
- Website
- WordPress
- Elementor
- Analytics and marketing
- Google Analytics
Public procurement
32 tenders recorded as contractor: 19 national ($1,407,223) and 13 EU ($1,284,836).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Aug 5, 2026 | 37.2026 Supply of laboratory equipment for the units of Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu | $3,492$3,492 | Uniwersytet Medyczny Im. Piastów Śląskich we Wrocławiu | |
| Jul 15, 2026 | AZP.25.1.31.2026 - Successive supply of small laboratory equipment for Zakłady i Kliniki UMB for scientific research purposes, divided into 4 lots | $34,446$34,446 | Uniwersytet Medyczny w Białymstoku | |
| Jul 9, 2026 | Supply of a fluorescence microscope with upgrade capability | $105.4K$105,413 | Centrum Medycznego Kształcenia Podyplomowego |
Authorized Representatives
Manner of representation
Each member of the management board is independently authorised to represent the company, make declarations and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Petr Kvapilage 61 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-05-25.
84 2490 0005 0000 4520 5128 7645- 22 2490 0005 0000 4600 4781 2979
- 29 2490 0005 0000 4600 9322 6216
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Meditechsp. z o.o. | $1,934,919.56 | meditech.com.pl | ||
| Labo Plussp. z o.o. | $1,527,808.22 | laboplus.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Rhinegene Polandsp. z o.o. | $968,404.11 | rhinegene.pl | ||
| Meditechsp. z o.o. | $934,565.46 | meditech.pl | ||
| Move-Xsp. z o.o. | $870,473.73 | move-x.eu | ||
| Farmatorsp. z o.o. | $731,930.27 | farmator.eu | ||
| Polygensp. z o.o. | $575,907.38 | polygen.pl | ||
| Datamobisp. z o.o. | $496,063.97 | datamobi.pl | ||
| Medis Polandsp. z o.o. | $487,846.47 | medis.com |
FAQ
Last updated: 2026-10-07